...
首页> 外文期刊>Journal of Molecular Modeling >Prediction of zanamivir efficiency over the possible 2009 Influenza A (H1N1) mutants by multiple molecular dynamics simulations and free energy calculations
【24h】

Prediction of zanamivir efficiency over the possible 2009 Influenza A (H1N1) mutants by multiple molecular dynamics simulations and free energy calculations

机译:通过多种分子动力学模拟和自由能计算预测zanamivir对2009年可能的A型流感(H1N1)突变体的效率

获取原文
获取原文并翻译 | 示例

摘要

As one of the most important antiviral drugs against 2009 influenza A (H1N1), will zanamivir be effective for the possible drug resistant mutants? To answer this question, we combined multiple molecular dynamics simulations and molecular mechanics generalized Born surface area (MM-GBSA) calculations to study the efficiency of zanamivir over the most frequent drug-resistant strains of neuraminidase including R293K, R152K, E119A/D and H275Y mutants. The calculated results indicate that the modeled mutants of the 2009-H1N1 strains except H275Y will be significantly resistant to zanamivir. The resistance to zanamivir is mainly caused by the loss of polar interactions. The identified potential resistance sites in this study will be useful for the development of new effective anti-influenza drugs and to avoid the occurrence of the state without effective drugs to new mutant influenza strains.
机译:扎那米韦作为对抗2009年甲型H1N1流感最重要的抗病毒药物之一,对可能的耐药突变株是否有效?为了回答这个问题,我们结合了多种分子动力学模拟和分子力学广义博恩表面积(MM-GBSA)计算,以研究扎那米韦对神经氨酸酶最常见耐药菌株(包括R293K,R152K,E119A / D和H275Y)的效率突变体。计算结果表明,除H275Y外,2009-H1N1菌株的建模突变体将对扎那米韦具有显着抗性。对扎那米韦的耐药性主要是由极性相互作用的丧失引起的。在这项研究中确定的潜在耐药位点将有助于开发新的有效抗流感药物,并避免在没有有效药物的情况下出现新的突变流感病毒株。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号